SLC67A1 and neoplasm: However, in the present study, we identified that SLC22A18 overexpression can effectively inhibit the growth and adhesion of U251 glioma cells, and additionally, overexpression of SLC22A18 can trigger apoptosis in glioma cells in vitro and delay tumor growth in vivo.